MedTrace Logo

Topical Silver for Prevention of Wound Infection After Cesarean Delivery

NCT01169064 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 475

Last updated 2017-05-30

Study results available
· View outcomes & findings →

Summary

A common concern in any surgical procedure is the occurrence of infection. Silver-containing treatments are popular and used in wound treatment; however, there is presently little evidence of the effectiveness of silver-containing treatment for the prevention of obstetrical wound infection. We plan to investigate the rate of infection in women experiencing cesarean sections at Vanderbilt University Medical Center (VUMC) by comparing the infection rate based on a randomized choice of silver-containing wound dressings to soft cloth adhesive wound dressings.

Conditions

  • Wound Infection

Interventions

DEVICE

Silver-containing surgical dressing

Dressing placed over surgical incision and remain for 3-5 days

DEVICE

Cloth adhesive dressing

Cloth adhesive dressing placed over surgical incision and remains for 3-5 days

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Kelly A. Bennett, MD · Vanderbilt University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01169064 on ClinicalTrials.gov